Sandra
Hervas Stubbs
Profesional Investigadora
Publications dans lesquelles il/elle collabore avec Sandra Hervas Stubbs (16)
2023
-
Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease
GLIA, Vol. 71, Núm. 3, pp. 571-587
2021
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
2015
-
Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver
Liver International, Vol. 35, Núm. 4, pp. 1274-1289
2012
2011
-
Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
PLoS ONE, Vol. 6, Núm. 3
-
Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
Gut, Vol. 60, Núm. 3, pp. 341-349
2010
2009
-
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
European Journal of Immunology, Vol. 39, Núm. 9, pp. 2424-2436
2008
-
Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells
Gene Therapy, Vol. 15, Núm. 7, pp. 473-483
-
Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies
Trends in Pharmacological Sciences, Vol. 29, Núm. 8, pp. 383-390
-
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma
Clinical Cancer Research, Vol. 14, Núm. 21, pp. 6895-6906
2007
-
Absence of surface expression of CD137 (4-1BB) on Myeloid-derived suppressor cells
Inmunologia, Vol. 26, Núm. 3, pp. 121-126
-
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615
-
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295
2006
-
Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena
Clinical Cancer Research
-
Recombinant Adenoviral Vectors Turn on the Type I Interferon System without Inhibition of Transgene Expression and Viral Replication
Molecular Therapy, Vol. 14, Núm. 1, pp. 129-138